Synthetic Biology Patent Applications Expected to Present New Challenges
June 6, 2008
Foley Partner Mark Waxman and Patent Agent Vid Mohan-Ram recently authored an article titled, “Synthetic Biology Patent Applications Expected to Present New Challenges,” in the June 6, 2008 issue of Life Sciences Law & Industry Report. The article addresses the U.S. patent applications that expressly focus on synthetic biology, and how the U.S. Patent & Trademark Office is handling and examining them.
Reproduced with permission from Life Sciences Law & Industry Report, Vol. 2, No. 12 (June 6, 2008) pp. 473-474. Copyright 2008 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.